RAFT enables the development of very complex molecules that can be used for a wide range of products. The technology is already generating major improvements in the areas of coatings and paints, electroactive materials, fuel additives, biomaterials, polymer synthesis, personal care, drug delivery agents and car components.
About 3200 papers have been published on RAFT developments, coupled with over 200 patents granted to research and commercial institutions globally.
Monomer Polymer, a US company which specialises in manufacturing specialty monomers and sophisticated polymers has agreed to market the technology worldwide.
Monomer-Polymer and Dajac Labs CEO Stephen Bell said having access to RAFT technology will allow the company to “undertake controlled radical polymerizations and consequently, create additional success and opportunity in material development”.
Additionally, Monomer-Polymer said that the licensing agreement would enable the company to strengthen their position as a key player in the synthesis, development and scale-up of specialty monomers and resulting polymer systems. A unique aspect of Monomer-Polymer’s chemistries is the internal expertise with organosilanes which should open up unique uses of RAFT to create polymers with organosilicon functionalities in the architecture.
“This new technology is creating global impact and has been licensed by a wide range of Australian and multinational companies,” stated Kate Dawson, CSIRO’s Business Development Manager for RAFT.